Evidence map›Paper›PMID 35940839›Full record

SynthesisBMJ open2022

Type 2 diabetes and hypertension in Vietnam: a systematic review and meta-analysis of studies between 2000 and 2020.

Tuhin Biswas, Nam Tran, Hoang Thi My Hanh, Pham Van Hien, Nguyen Thi Thu Cuc, Phan Hong Van, Khuong Anh Tuan, Tran Thi Mai Oanh, Abdullah Mamun

Open access · goldAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in BMJ open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
5.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 25 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Tuhin BiswasInstitute for Social Science Research, The University of Queensland, Brisbane, Queensland, Australia.ORCID 0000-0002-7837-0306
Nam TranInstitute for Social Science Research, The University of Queensland, Brisbane, Queensland, Australia n.tranthanh@uq.edu.au.ORCID 0000-0002-0794-881X
Hoang Thi My HanhDepartment of Social Medicine and Population, Health Strategy and Policy Institute, Vietnam Ministry of Health, Hanoi, Vietnam.
Pham Van HienWorld Health Organization, Hanoi, Vietnam.
Nguyen Thi Thu CucDepartment of Scientific Management, Training, and International Collaboration, Health Strategy and Policy Institute, Vietnam Ministry of Health, Hanoi, Vietnam.
Phan Hong VanDepartment of Scientific Management, Training, and International Collaboration, Health Strategy and Policy Institute, Vietnam Ministry of Health, Hanoi, Vietnam.
Khuong Anh TuanHealth Strategy and Policy Institute, Vietnam Ministry of Health, Hanoi, Vietnam.
Tran Thi Mai OanhHealth Strategy and Policy Institute, Vietnam Ministry of Health, Hanoi, Vietnam.
Abdullah MamunInstitute for Social Science Research, The University of Queensland, Brisbane, Queensland, Australia.ORCID 0000-0002-1535-8086
Health Strategy and Policy Institute · VNThe University of Queensland · AU

Funding

World Health Organization 001
6 · The paper itself

Abstract

objectivesThe objective of this study was to determine the level of type 2 diabetes (T2DM) and hypertension (HTN) in Vietnam and to assess the trend and recommend the future direction of prevention research efforts.

designWe searched scientific literature, databases including PubMed, EMBASE, CINHAL and Google Scholar; grey literature and reference lists for primary research published, nation database websites between 1 January 2000 and 30 September 2020. We adapted the modified Newcastle Ottawa Scale for assessing the quality of the study, as recommended by the Cochrane Collaboration.

resultsIn total, 83 studies met our inclusion criteria, representing data of approximately 239 034 population of more than 15 years of age in Vietnam. The findings show that prevalence rates varied widely across studies, from 1.0% to 29.0% for T2DM and 2.0% to 47.0% for HTN. For the total study period, pooled prevalence of T2DM and HTN in Vietnam for all studies was 6.0% (95% CI: 4.0% to 7.0%) and 25% (95% CI: 19% to 31%), respectively. Prevalence rate of both T2DM and HTN was higher among the male population compared with female counterpart.

conclusionThere is evidence of a rising trend of HTN and T2DM prevalence in Vietnam. Future research should focus on the major drivers, incidence and prognosis of T2DM and HTN. Policy approaches should base upon the trends of T2DM and HTN in Vietnam over the last 20 years and pay more attention on the effective interventions to combat T2DM and HTN. In our study, we included both English and Vietnamese language articles and seems that majority of the articles came from Vietnamese language. PROSPERO REGISTRATION NUMBER: CRD42020182959.

Indexed as

Diabetes Mellitus, Type 2HypertensionFemaleHumansIncidenceMalePrevalenceVietnamDIABETES & ENDOCRINOLOGYHealth policyHypertensionIschaemic heart disease

Identifiers

PMID35940839
PMCPMC9364409
OpenAlexW4290672965

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.